
Artificial Intelligence (AI) in Medical Diagnostics
Description
Global Artificial Intelligence (AI) in Medical Diagnostics Market to Reach US$4.4 Billion by 2030
The global market for Artificial Intelligence (AI) in Medical Diagnostics estimated at US$1.3 Billion in the year 2024, is expected to reach US$4.4 Billion by 2030, growing at a CAGR of 22.2% over the analysis period 2024-2030. Software, one of the segments analyzed in the report, is expected to record a 24.0% CAGR and reach US$2.4 Billion by the end of the analysis period. Growth in the Hardware segment is estimated at 17.0% CAGR over the analysis period.
The U.S. Market is Estimated at US$366.3 Million While China is Forecast to Grow at 20.9% CAGR
The Artificial Intelligence (AI) in Medical Diagnostics market in the U.S. is estimated at US$366.3 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$663.5 Million by the year 2030 trailing a CAGR of 20.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 20.1% and 18.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 14.6% CAGR.
Global Artificial Intelligence (AI) in Medical Diagnostics Market – Key Trends & Drivers Summarized
The Rapid Rise of AI in Medical Diagnostics
Artificial Intelligence (AI) is revolutionizing the field of medical diagnostics by significantly improving the speed, accuracy, and accessibility of disease detection and interpretation. As healthcare systems around the world contend with increasing patient loads, shortages of skilled professionals, and the rising complexity of diagnostic imaging and data, AI has emerged as a powerful enabler of smarter, data-driven diagnostics. By leveraging machine learning (ML), deep learning, computer vision, and natural language processing (NLP), AI systems are now capable of interpreting medical images, lab data, pathology reports, and genetic profiles with unprecedented precision. This shift is not only enhancing clinical decision-making but also facilitating earlier and more targeted interventions across various conditions, including cancer, cardiovascular diseases, neurological disorders, and infectious diseases.
One of the most prominent trends in the market is the integration of AI into radiology and diagnostic imaging. AI algorithms are being trained on massive datasets to detect abnormalities in X-rays, CT scans, MRIs, and ultrasounds—flagging areas of concern for radiologists and reducing diagnostic errors. In parallel, AI-powered pathology platforms are transforming how tissue samples are analyzed by identifying patterns in histopathological images that may be invisible to the human eye. Another key trend is the use of AI in point-of-care diagnostics and wearable health technologies, where real-time data collection is paired with AI to monitor vital signs, detect arrhythmias, or flag early signs of disease, allowing for timely intervention and improved patient outcomes.
How Is AI Enhancing Accuracy and Efficiency in Disease Detection?
AI systems are dramatically enhancing diagnostic accuracy, especially in areas where early detection is critical. In oncology, for instance, AI is being used to detect early-stage breast, lung, prostate, and skin cancers from imaging scans with accuracy comparable to or exceeding that of experienced clinicians. Deep learning algorithms can recognize subtle patterns, calculate tumor growth rates, and differentiate between benign and malignant lesions. In cardiology, AI-based ECG and imaging analysis tools assist in identifying arrhythmias, structural abnormalities, and even predicting heart failure risks based on longitudinal patient data.
In terms of efficiency, AI reduces the diagnostic workload by automating repetitive tasks and triaging cases based on urgency. This is particularly valuable in overburdened health systems where radiologists and lab technicians face increasing volumes of diagnostic tests. AI systems can prioritize scans with suspected anomalies, provide preliminary assessments, and reduce turnaround time significantly. In pathology, AI tools are enabling digital workflows where biopsy slides are scanned and analyzed at scale, accelerating diagnosis and enabling remote consultations. By streamlining diagnostics, AI helps clinicians make faster, more informed decisions, ultimately improving patient care and resource utilization.
Where Is AI Expanding Its Impact Across Diagnostic Specialties?
Beyond imaging and pathology, AI is being integrated into a wide range of diagnostic specialties. In genomics, AI platforms are helping interpret complex DNA and RNA sequencing data to identify genetic mutations, predict disease susceptibility, and guide precision medicine strategies. In infectious disease diagnostics, AI is being used to analyze clinical symptoms, lab data, and even microbial genomics to detect outbreaks, track resistance patterns, and optimize treatment protocols. During the COVID-19 pandemic, AI played a key role in the rapid analysis of viral spread, diagnostic imaging interpretation, and triage automation.
In neurology, AI systems are supporting early diagnosis of conditions like Alzheimer’s, Parkinson’s, and multiple sclerosis by analyzing imaging, speech patterns, and cognitive test results. In ophthalmology, AI is enabling early detection of diabetic retinopathy, glaucoma, and macular degeneration through retinal imaging analysis. AI-driven diagnostic tools are also being deployed in dermatology to differentiate between various skin lesions using mobile apps and dermatoscopic imaging. As electronic health records (EHRs) become more interoperable and rich in unstructured data, NLP-powered AI systems are helping extract insights from physician notes, lab reports, and patient histories to support comprehensive diagnostics.
What’s Fueling the Growth in the AI in Medical Diagnostics Market?
The growth in the AI in medical diagnostics market is driven by several factors closely linked to technological advancements, clinical needs, and global healthcare transformations. One of the primary growth drivers is the increasing volume of medical imaging and diagnostic data, which is overwhelming human capacity for interpretation. AI provides a scalable solution by rapidly processing large datasets and highlighting critical findings with high accuracy. Additionally, the rising prevalence of chronic diseases such as cancer, cardiovascular disorders, and diabetes is creating an urgent need for faster, more reliable diagnostic tools.
The advancement of deep learning, image recognition, and natural language processing algorithms, combined with the availability of large annotated datasets and cloud computing infrastructure, is enabling the development and deployment of sophisticated AI diagnostic tools. Regulatory bodies are increasingly approving AI-based diagnostic devices for clinical use, signaling a growing trust in AI’s clinical efficacy and safety. Furthermore, the expansion of telehealth and remote diagnostics—especially post-pandemic—is pushing healthcare providers to adopt AI-powered tools that support virtual consultations and at-home diagnostics.
AI’s potential to reduce healthcare costs by minimizing misdiagnoses, avoiding unnecessary procedures, and improving early detection is also driving adoption among payers and providers. Additionally, partnerships between healthcare institutions, AI startups, and tech giants are accelerating innovation and bringing cutting-edge diagnostic solutions to market. The rising interest in personalized and preventative medicine is further aligning with AI’s capabilities in risk prediction and patient stratification. Together, these drivers are not only fueling market growth but are also positioning AI as a central pillar in the future of diagnostic medicine—where precision, speed, and intelligence converge to deliver better health outcomes.
SCOPE OF STUDY:The report analyzes the Artificial Intelligence (AI) in Medical Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:
Segments:
Component (Software, Hardware, Services); Diagnosis Type (Neurology, Radiology, Oncology, Pulmonology, Cardiology, Other Diagnosis Types); End-User (Hospitals, Diagnostic Centers, Other End-Users)
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.
Select Competitors (Total 22 Featured) -
- Agfa Healthcare Corporation
- Aidoc
- AliveCor, Inc.
- Caption Health
- Elevance Health, Inc.
- HeartFlow
- Intelegain Technologies
- Siemens Healthineers AG
- VisualDx.
We`re transforming market and competitive intelligence with validated expert content and AI tools.
Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.
The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.
Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.
Table of Contents
- I. METHODOLOGY
- II. EXECUTIVE SUMMARY
- 1. MARKET OVERVIEW
- Influencer Market Insights
- Tariff Impact on Global Supply Chain Patterns
- Global Economic Update
- Artificial Intelligence (AI) in Medical Diagnostics – Global Key Competitors Percentage Market Share in 2025 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
- 2. FOCUS ON SELECT PLAYERS
- 3. MARKET TRENDS & DRIVERS
- AI Enhancements in Imaging Technologies Propel Early Disease Detection
- Growth of AI Applications in Genomic Analysis Expands Personalized Medicine
- AI-Driven Predictive Diagnostics Strengthen Patient Outcome Predictions
- Integration of AI in Laboratory Information Systems Enhances Diagnostic Accuracy
- Machine Learning Algorithms for Cancer Detection Throw the Spotlight on Oncology
- Impact of AI on Reducing Diagnostic Errors and Improving Efficiency
- AI Tools for Cardiovascular Imaging Propel Non-Invasive Diagnostics
- Role of AI in Handling Healthcare Big Data Generates Significant Insights
- AI-Powered Mobile Apps for Health Monitoring Drive Patient Engagement
- Ethical AI Use in Medical Diagnostics Strengthens Patient Trust
- Expansion of AI in Rare Disease Research and Diagnosis
- Data Privacy Concerns and AI Regulation in Medical Practices
- 4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World Artificial Intelligence (AI) in Medical Diagnostics Market Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030
- TABLE 2: World Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 3: World Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
- TABLE 4: World 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2022, 2025 & 2030
- TABLE 5: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 6: World Historic Review for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
- TABLE 7: World 8-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2025 & 2030
- TABLE 8: World Recent Past, Current & Future Analysis for Hardware by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 9: World Historic Review for Hardware by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
- TABLE 10: World 8-Year Perspective for Hardware by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2025 & 2030
- TABLE 11: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 12: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
- TABLE 13: World 8-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2025 & 2030
- TABLE 14: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 15: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
- TABLE 16: World 8-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2025 & 2030
- TABLE 17: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 18: World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
- TABLE 19: World 8-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2025 & 2030
- TABLE 20: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 21: World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
- TABLE 22: World 8-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2025 & 2030
- TABLE 23: World Recent Past, Current & Future Analysis for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 24: World Historic Review for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
- TABLE 25: World 8-Year Perspective for Neurology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2025 & 2030
- TABLE 26: World Recent Past, Current & Future Analysis for Radiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 27: World Historic Review for Radiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
- TABLE 28: World 8-Year Perspective for Radiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2025 & 2030
- TABLE 29: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 30: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
- TABLE 31: World 8-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2025 & 2030
- TABLE 32: World Recent Past, Current & Future Analysis for Pulmonology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 33: World Historic Review for Pulmonology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
- TABLE 34: World 8-Year Perspective for Pulmonology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2025 & 2030
- TABLE 35: World Recent Past, Current & Future Analysis for Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 36: World Historic Review for Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
- TABLE 37: World 8-Year Perspective for Cardiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2025 & 2030
- TABLE 38: World Recent Past, Current & Future Analysis for Other Diagnosis Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 39: World Historic Review for Other Diagnosis Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
- TABLE 40: World 8-Year Perspective for Other Diagnosis Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2025 & 2030
- III. MARKET ANALYSIS
- UNITED STATES
- Artificial Intelligence (AI) in Medical Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
- TABLE 41: USA Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 42: USA Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by Component - Software, Hardware and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
- TABLE 43: USA 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2022, 2025 & 2030
- TABLE 44: USA Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by End-user - Hospitals, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 45: USA Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by End-user - Hospitals, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
- TABLE 46: USA 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Users for the Years 2022, 2025 & 2030
- TABLE 47: USA Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by Diagnosis Type - Neurology, Radiology, Oncology, Pulmonology, Cardiology and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 48: USA Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by Diagnosis Type - Neurology, Radiology, Oncology, Pulmonology, Cardiology and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
- TABLE 49: USA 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Neurology, Radiology, Oncology, Pulmonology, Cardiology and Other Diagnosis Types for the Years 2022, 2025 & 2030
- CANADA
- TABLE 50: Canada Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 51: Canada Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by Component - Software, Hardware and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
- TABLE 52: Canada 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2022, 2025 & 2030
- TABLE 53: Canada Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by End-user - Hospitals, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 54: Canada Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by End-user - Hospitals, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
- TABLE 55: Canada 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Users for the Years 2022, 2025 & 2030
- TABLE 56: Canada Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by Diagnosis Type - Neurology, Radiology, Oncology, Pulmonology, Cardiology and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 57: Canada Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by Diagnosis Type - Neurology, Radiology, Oncology, Pulmonology, Cardiology and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
- TABLE 58: Canada 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Neurology, Radiology, Oncology, Pulmonology, Cardiology and Other Diagnosis Types for the Years 2022, 2025 & 2030
- JAPAN
- Artificial Intelligence (AI) in Medical Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
- TABLE 59: Japan Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 60: Japan Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by Component - Software, Hardware and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
- TABLE 61: Japan 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2022, 2025 & 2030
- TABLE 62: Japan Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by End-user - Hospitals, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 63: Japan Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by End-user - Hospitals, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
- TABLE 64: Japan 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Users for the Years 2022, 2025 & 2030
- TABLE 65: Japan Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by Diagnosis Type - Neurology, Radiology, Oncology, Pulmonology, Cardiology and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 66: Japan Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by Diagnosis Type - Neurology, Radiology, Oncology, Pulmonology, Cardiology and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
- TABLE 67: Japan 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Neurology, Radiology, Oncology, Pulmonology, Cardiology and Other Diagnosis Types for the Years 2022, 2025 & 2030
- CHINA
- Artificial Intelligence (AI) in Medical Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
- TABLE 68: China Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 69: China Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by Component - Software, Hardware and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
- TABLE 70: China 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2022, 2025 & 2030
- TABLE 71: China Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by End-user - Hospitals, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 72: China Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by End-user - Hospitals, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
- TABLE 73: China 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Users for the Years 2022, 2025 & 2030
- TABLE 74: China Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by Diagnosis Type - Neurology, Radiology, Oncology, Pulmonology, Cardiology and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 75: China Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by Diagnosis Type - Neurology, Radiology, Oncology, Pulmonology, Cardiology and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
- TABLE 76: China 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Neurology, Radiology, Oncology, Pulmonology, Cardiology and Other Diagnosis Types for the Years 2022, 2025 & 2030
- EUROPE
- Artificial Intelligence (AI) in Medical Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
- TABLE 77: Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 78: Europe Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
- TABLE 79: Europe 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2022, 2025 & 2030
- TABLE 80: Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 81: Europe Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by Component - Software, Hardware and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
- TABLE 82: Europe 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2022, 2025 & 2030
- TABLE 83: Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by End-user - Hospitals, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 84: Europe Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by End-user - Hospitals, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
- TABLE 85: Europe 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Users for the Years 2022, 2025 & 2030
- TABLE 86: Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by Diagnosis Type - Neurology, Radiology, Oncology, Pulmonology, Cardiology and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 87: Europe Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by Diagnosis Type - Neurology, Radiology, Oncology, Pulmonology, Cardiology and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
- TABLE 88: Europe 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Neurology, Radiology, Oncology, Pulmonology, Cardiology and Other Diagnosis Types for the Years 2022, 2025 & 2030
- FRANCE
- Artificial Intelligence (AI) in Medical Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
- TABLE 89: France Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 90: France Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by Component - Software, Hardware and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
- TABLE 91: France 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2022, 2025 & 2030
- TABLE 92: France Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by End-user - Hospitals, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 93: France Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by End-user - Hospitals, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
- TABLE 94: France 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Users for the Years 2022, 2025 & 2030
- TABLE 95: France Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by Diagnosis Type - Neurology, Radiology, Oncology, Pulmonology, Cardiology and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 96: France Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by Diagnosis Type - Neurology, Radiology, Oncology, Pulmonology, Cardiology and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
- TABLE 97: France 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Neurology, Radiology, Oncology, Pulmonology, Cardiology and Other Diagnosis Types for the Years 2022, 2025 & 2030
- GERMANY
- Artificial Intelligence (AI) in Medical Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
- TABLE 98: Germany Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 99: Germany Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by Component - Software, Hardware and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
- TABLE 100: Germany 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2022, 2025 & 2030
- TABLE 101: Germany Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by End-user - Hospitals, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 102: Germany Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by End-user - Hospitals, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
- TABLE 103: Germany 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Users for the Years 2022, 2025 & 2030
- TABLE 104: Germany Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by Diagnosis Type - Neurology, Radiology, Oncology, Pulmonology, Cardiology and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 105: Germany Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by Diagnosis Type - Neurology, Radiology, Oncology, Pulmonology, Cardiology and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
- TABLE 106: Germany 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Neurology, Radiology, Oncology, Pulmonology, Cardiology and Other Diagnosis Types for the Years 2022, 2025 & 2030
- ITALY
- TABLE 107: Italy Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 108: Italy Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by Component - Software, Hardware and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
- TABLE 109: Italy 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2022, 2025 & 2030
- TABLE 110: Italy Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by End-user - Hospitals, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 111: Italy Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by End-user - Hospitals, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
- TABLE 112: Italy 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Users for the Years 2022, 2025 & 2030
- TABLE 113: Italy Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by Diagnosis Type - Neurology, Radiology, Oncology, Pulmonology, Cardiology and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 114: Italy Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by Diagnosis Type - Neurology, Radiology, Oncology, Pulmonology, Cardiology and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
- TABLE 115: Italy 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Neurology, Radiology, Oncology, Pulmonology, Cardiology and Other Diagnosis Types for the Years 2022, 2025 & 2030
- UNITED KINGDOM
- Artificial Intelligence (AI) in Medical Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
- TABLE 116: UK Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 117: UK Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by Component - Software, Hardware and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
- TABLE 118: UK 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2022, 2025 & 2030
- TABLE 119: UK Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by End-user - Hospitals, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 120: UK Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by End-user - Hospitals, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
- TABLE 121: UK 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Users for the Years 2022, 2025 & 2030
- TABLE 122: UK Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by Diagnosis Type - Neurology, Radiology, Oncology, Pulmonology, Cardiology and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 123: UK Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by Diagnosis Type - Neurology, Radiology, Oncology, Pulmonology, Cardiology and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
- TABLE 124: UK 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Neurology, Radiology, Oncology, Pulmonology, Cardiology and Other Diagnosis Types for the Years 2022, 2025 & 2030
- REST OF EUROPE
- TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 126: Rest of Europe Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by Component - Software, Hardware and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
- TABLE 127: Rest of Europe 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2022, 2025 & 2030
- TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by End-user - Hospitals, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 129: Rest of Europe Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by End-user - Hospitals, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
- TABLE 130: Rest of Europe 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Users for the Years 2022, 2025 & 2030
- TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by Diagnosis Type - Neurology, Radiology, Oncology, Pulmonology, Cardiology and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 132: Rest of Europe Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by Diagnosis Type - Neurology, Radiology, Oncology, Pulmonology, Cardiology and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
- TABLE 133: Rest of Europe 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Neurology, Radiology, Oncology, Pulmonology, Cardiology and Other Diagnosis Types for the Years 2022, 2025 & 2030
- ASIA-PACIFIC
- Artificial Intelligence (AI) in Medical Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
- TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 135: Asia-Pacific Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by Component - Software, Hardware and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
- TABLE 136: Asia-Pacific 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2022, 2025 & 2030
- TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by End-user - Hospitals, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 138: Asia-Pacific Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by End-user - Hospitals, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
- TABLE 139: Asia-Pacific 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Users for the Years 2022, 2025 & 2030
- TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by Diagnosis Type - Neurology, Radiology, Oncology, Pulmonology, Cardiology and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 141: Asia-Pacific Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by Diagnosis Type - Neurology, Radiology, Oncology, Pulmonology, Cardiology and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
- TABLE 142: Asia-Pacific 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Neurology, Radiology, Oncology, Pulmonology, Cardiology and Other Diagnosis Types for the Years 2022, 2025 & 2030
- REST OF WORLD
- TABLE 143: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 144: Rest of World Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by Component - Software, Hardware and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
- TABLE 145: Rest of World 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2022, 2025 & 2030
- TABLE 146: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by End-user - Hospitals, Diagnostic Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 147: Rest of World Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by End-user - Hospitals, Diagnostic Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
- TABLE 148: Rest of World 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Users for the Years 2022, 2025 & 2030
- TABLE 149: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Medical Diagnostics by Diagnosis Type - Neurology, Radiology, Oncology, Pulmonology, Cardiology and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 150: Rest of World Historic Review for Artificial Intelligence (AI) in Medical Diagnostics by Diagnosis Type - Neurology, Radiology, Oncology, Pulmonology, Cardiology and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
- TABLE 151: Rest of World 8-Year Perspective for Artificial Intelligence (AI) in Medical Diagnostics by Diagnosis Type - Percentage Breakdown of Value Sales for Neurology, Radiology, Oncology, Pulmonology, Cardiology and Other Diagnosis Types for the Years 2022, 2025 & 2030
- IV. COMPETITION
Pricing
Currency Rates